Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 55 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Shilan M.

Oman

USD 55 /hr

Senior Medical Writer | Pharmacoeconomics & HTA Specialist | PharmD, PhD | 32 Publications | h-index 17

Profile Summary

I am a PharmD-trained researcher with a PhD in Pharmacoeconomics, 15+ years of experience across clinical, academic, and regulatory settings, and 32 peer-reviewed publications (h-index: 17, 1,950+ citations). The majority of my work consists of systematic reviews and meta-analyses published in high-impact journals including Expert Opinion series. What I bring to your project: • Systematic reviews & meta-analyses (PRISMA-compliant, RevMan, Stata, R) • Health Technology Assessment (HTA) & cost-effectiveness modeling (TreeAge, ISPOR-standard methods) • Manuscript writing, editing & journal submission preparation • Evidence synthesis for pharmaceutical and regulatory submissions • Budget impact analysis & real-world evidence generation • Peer reviewer for international journals My background spans pharmacology, toxicology, gastroenterology, neurology (multiple sclerosis), oncology, and pharmacoeconomics — giving me the versatility to work across therapeutic areas with scientific precision. I have conducted evidence synthesis and HTA reports for reimbursement decisions on 20+ drug molecules. This regulatory experience means I understand not just how to write — but what decision-makers actually need. Every deliverable I produce is evidence-based, rigorously structured, and written to the standard of peer-reviewed publication. Let's discuss your project.

Subject Matter Expertise

• ☆ Biostatistics
• ☆ Statistics
• ☆ Meta-Analysis
• ☆ STATA
• ☆ R
• ☆ Pharmacy
• ☆ Pharmacy Education
• ☆ Clinical Pharmacy
• ☆ Drug Development
• ☆ Preclinical ADME/PK/PD
• ☆ Drug-Drug Interactions
• ☆ Preclinical Research
• ☆ Preclinical Pharmacology
• ☆ Investigational New Drug (IND) Application Consulting
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Drug Efficacy Testing
• ☆ Bioavailability
• ☆ Clinical Trials
• ☆ Clinical Trial Design
• ☆ Clinical Data Management
• ☆ Clinical Trials Data Analysis
• ☆ Pharmacovigilance/Drug Safety Monitoring
• ☆ Neurology
• ☆ Oncology
• ☆ Gastroenterology & Hepatology
• ☆ Crohn's Disease
• ☆ Irritable Bowel Syndrome (IBS)
• ☆ Health Technology Assessment
• ☆ Pharmaceutical Management
• ☆ Medical Writing
• ☆ Literature Review
• ☆ Systematic Literature Review

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Clinical Trial Documentation, Medical Writing, Technical Writing, Business & Legal Writing, Copywriting, Creative Writing, Newswriting

Research Market Research, Meta-Research, Gray Literature Search, Systematic Literature Review

Consulting Healthcare Consulting

Data & AI Statistical Analysis

Product Development Product Evaluation, Product Launch Support

Work Experience

Research Assistant

Pharmaceutical Sciences Research Center, TUMS

January 2026 - Present

Education

PhD

Tehran University of Medical Sciences

October 2019 - October 2024

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi (2024). Pharmacokinetic considerations for drugs that treat diarrhea-predominant irritable bowel syndrome: what’s new? . Expert Opinion on Drug Metabolism & Toxicology.

Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi (2024). Drugs of the future for diarrhea-predominant irritable bowel syndrome: an overview of current investigational drugs . Expert Opinion on Investigational Drugs.

Shilan Mozaffari, Taraneh Mousavi, Shekoufeh Nikfar, Mohammad Abdollahi (2023). Common gastrointestinal drug-drug interactions in geriatrics and the importance of careful planning . Expert Opinion on Drug Metabolism & Toxicology.

Mozaffari, S., Mousavi, T., Nikfar, S., Abdollahi, M.(2023). Common gastrointestinal drug-drug interactions in geriatrics and the importance of careful planning . Expert Opinion on Drug Metabolism and Toxicology. 19. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 807-828.

Mozaffari, Shilan, Nikfar, Shekoufeh, Daniali, Marzieh, Abdollahi, Mohammad (2020). The pharmacological management of constipation in patients with Parkinson's disease: a much-needed relief . Expert Opinion on Pharmacotherapy.

Mozaffari, S., Nikfar, S., Daniali, M., Abdollahi, M.(2020). The pharmacological management of constipation in patients with Parkinson’s disease: a much-needed relief . Expert Opinion on Pharmacotherapy. 21. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 701-707.

Dellis AE, Athanasios E. Dellis, Mozaffari S, Shilan Mozaffari, Shekoufeh Nikfar, Athanasios G. Papatsoris, Mohammad Abdollahi (2019). Is there an appropriate strategy for treating co-morbid irritable bowel syndrome and bladder pain syndrome? . Expert Opinion on Pharmacotherapy.

Dellis, A.E., Mozaffari, S., Nikfar, S., Papatsoris, A.G., Abdollahi, M.(2019). Is there an appropriate strategy for treating co-morbid irritable bowel syndrome and bladder pain syndrome? . Expert Opinion on Pharmacotherapy. 20. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 411-414.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2018). Investigational opioid antagonists for treating opioid-induced bowel dysfunction . Expert Opinion on Investigational Drugs.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2018). Investigational opioid antagonists for treating opioid-induced bowel dysfunction . Expert Opinion on Investigational Drugs. 27. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 235-242.

Shilan Mozaffari, Shekoufeh Nikfar, Mohammad Abdollahi (2018). Methylnaltrexone bromide for the treatment of opioid-induced constipation . Expert Opinion on Pharmacotherapy.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2018). Methylnaltrexone bromide for the treatment of opioid-induced constipation . Expert Opinion on Pharmacotherapy. 19. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1127-1135.

Zaboli, Pardis, Abdollahi, Mohammad, Mozaffari, Shilan, Nikfar, Shekoufeh (2017). Tumor necrosis factor-alpha antibodies in fistulizing crohn's disease: An updated systematic review and meta-analysis . Journal of Research in Pharmacy Practice.

Didari, Tina, Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2015). Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis . World Journal of Gastroenterology.

Didari, T., Mozaffari, S., Nikfar, S., Abdollahi, M.(2015). Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis . World Journal of Gastroenterology. 21. (10). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3072-3084.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2015). Inflammatory bowel disease therapies discontinued between 2009 and 2014 . Expert Opinion on Investigational Drugs.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2015). Inflammatory bowel disease therapies discontinued between 2009 and 2014 . Expert Opinion on Investigational Drugs. 24. (7). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 949-956.

Mozaffari, S., Abdolghaffari, A.H., Nikfar, S., Abdollahi, M.(2015). Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: A systematic review with meta-analysis . Human and Experimental Toxicology. 34. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 445-459.

Didari, T., Solki, S., Mozaffari, S., Nikfar, S., Abdollahi, M.(2014). A systematic review of the safety of probiotics . Expert Opinion on Drug Safety. 13. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 227-239.

Moeinian, Mahsa, Ghasemi-Niri, Seyedeh Farnaz, Mozaffari, Shilan, Abdolghaffari, Amir Hossein, Baeeri, Maryam, Navaea-Nigjeh, Mona, Abdollahi, Mohammad (2014). Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis . World Journal of Gastroenterology.

Moeinian, M., Ghasemi-Niri, S.F., Mozaffari, S., Abdolghaffari, A.H., Baeeri, M., Navaea-Nigjeh, M., Abdollahi, M.(2014). Beneficial effect of butyrate, Lactobacillus casei and L-carnitine combination in preference to each in experimental colitis . World Journal of Gastroenterology. 20. (31). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 10876-10885.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2014). Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients . Archives of Medical Science.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2014). Efficacy and tolerability of renzapride in irritable bowel syndrome: A meta-analysis of randomized, controlled clinical trials including 2528 patients . Archives of Medical Science. 10. (1). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 10-18.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdolghaffari, Amir Hossein, Abdollahi, Mohammad (2014). New biologic therapeutics for ulcerative colitis and Crohn's disease . Expert Opinion on Biological Therapy.

Mozaffari, S., Nikfar, S., Abdolghaffari, A.H., Abdollahi, M.(2014). New biologic therapeutics for ulcerative colitis and Crohn's disease . Expert Opinion on Biological Therapy. 14. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 583-600.

Mozaffari, Shilan, Didari, Tina, Nikfar, Shekoufeh, Abdollahi, Mohammad (2014). Phase II drugs under clinical investigation for the treatment of chronic constipation . Expert Opinion on Investigational Drugs.

Mozaffari, S., Didari, T., Nikfar, S., Abdollahi, M.(2014). Phase II drugs under clinical investigation for the treatment of chronic constipation . Expert Opinion on Investigational Drugs. 23. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1485-1497.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2014). The safety of novel drugs used to treat irritable bowel syndrome . Expert Opinion on Drug Safety.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2014). The safety of novel drugs used to treat irritable bowel syndrome . Expert Opinion on Drug Safety. 13. (5). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 625-638.

Mozaffari, Shilan, Abdollahi, Mohammad (2013). A Review on the Role of Oxidative Stress and Inflammation in Necrotizing Enterocolitis and Benefits of the Phosphodiesterase Inhibitor Pentoxifylline . International Journal of Pharmacology.

Mozaffari, S., Abdollahi, M.(2013). A review on the role of oxidative stress and inflammation in necrotizing enterocolitis and benefits of the phosphodiesterase inhibitor pentoxifylline . International Journal of Pharmacology. 9. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 245-250.

Mozaffari, Shilan, Nikfar, Shekoufeh, Abdollahi, Mohammad (2013). Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome . Expert Opinion on Drug Metabolism & Toxicology.

Mozaffari, S., Nikfar, S., Abdollahi, M.(2013). Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome . Expert Opinion on Drug Metabolism and Toxicology. 9. (4). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 403-421.

Moeinian, Mahsa, Ghasemi-Niri, Seyedeh Farnaz, Mozaffari, Shilan, Abdollahi, Mohammad (2013). Synergistic effect of probiotics, butyrate and L-Carnitine in treatment of IBD . Journal of Medical Hypotheses and Ideas.

Moeinian, M., Farnaz Ghasemi-Niri, S., Mozaffari, S., Abdollahi, M.(2013). Synergistic effect of probiotics, butyrate and l-Carnitine in treatment of IBD . Journal of Medical Hypotheses and Ideas. 7. (2). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 50-53.

Asadi-Shahmirzadi, Azar, Mozaffari, Shilan, Sanei, Yara, Baeeri, Maryam, Hajiaghaee, Reza, Monsef-Esfahani, Hamid Reza, Abdollahi, Mohammad (2012). Benefit of Aloe vera and Matricaria recutita mixture in rat irritable bowel syndrome: Combination of antioxidant and spasmolytic effects . Chinese Journal of Integrative Medicine.

Ghasemi-Niri, Seyedeh Farnaz, Solki, Sara, Didari, Tina, Mozaffari, Shilan, Baeeri, Maryam, Rezvanfar, Mohammad Amin, Mohammadirad, Azadeh, Jamalifar, Hossein, Abdollahi, Mohammad (2012). Better Efficacy of <i>Lactobacillus casei</i> in Combination with <i>Bifidobacterium bifidum</i> or <i>Saccharomyces boulardii</i> in Recovery of Inflammatory Markers of Colitis in Rat . Asian Journal of Animal and Veterinary Advances.

Ghasemi-Niri, S.F., Solki, S., Didari, T., Mozaffari, S., Baeeri, M., Rezvanfar, M.A., Mohammahrad, A., Jamalifar, H., Abdollahi, M.(2012). Better efficacy of Lactobacillus casei in combination with Bifidobacterium bifidum or Saccharomyces boulardii in recovery of Inflammatory markers of colitis in rat . Asian Journal of Animal and Veterinary Advances. 7. (11). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1148-1156.

Mozaffari, Shilan, Hasani-Ranjbar, Shirin, Abdollahi, Mohammad (2012). The Mechanisms of Positive Effects of Melatonin in Dyslipidemia: A Systematic Review of Animal and Human Studies . International Journal of Pharmacology.

Mozaffari, S., Hasani-Ranjbar, S., Abdollahi, M.(2012). The mechanisms of positive effects of melatonin in dyslipidemia: A systematic review of animal and human studies . International Journal of Pharmacology. 8. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 496-509.

Mozaffari, Shilan, Esmaily, Hadi, Rahimi, Roja, Baeeri, Maryam, Sanei, Yara, Asadi-Shahmirzadi, Azar, Salehi-Surmaghi, Mohammad-Hossein, Abdollahi, Mohammad (2011). Effects of <i>Hypericum perforatum</i> extract on rat irritable bowel syndrome . Pharmacognosy Magazine.

Mozaffari, S., Esmaily, H., Rahimi, R., Baeeri, M., Sanei, Y., Asadi-Shahmirzadi, A., Salehi-Surmaghi, M.-H., Abdollahi, M.(2011). Effects of Hypericum perforatum extract on rat irritable bowel syndrome . Pharmacognosy Magazine. 7. (27). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 213-223.

Mozaffari, Shilan, Abdollahi, Mohammad (2011). Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences . Current Pharmaceutical Design.

Mozaffari, S., Abdollahi, M.(2011). Melatonin, a promising supplement in inflammatory bowel disease: a comprehensive review of evidences . Current pharmaceutical design. 17. (38). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4372-4378.

Mozaffari, Shilan, Rahimi, Roja, Abdollahi, Mohammad (2010). Implications of Melatonin Therapy in Irritable Bowel Syndrome: A Systematic Review . Current Pharmaceutical Design.

Mozaffari, S., Rahimi, R., Abdollahi, M.(2010). Implications of melatonin therapy in irritable bowel syndrome: A systematic review . Current Pharmaceutical Design. 16. (33). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 3646-3655.

Rahimi, Roja, Mozaffari, Shilan, Abdollahi, Mohammad (2009). On the Use of Herbal Medicines in Management of Inflammatory Bowel Diseases: A Systematic Review of Animal and Human Studies . Digestive Diseases and Sciences.

Rahimi, R., Mozaffari, S., Abdollahi, M.(2009). On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal and human studies . Digestive Diseases and Sciences. 54. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 471-480.

BOOK CHAPTER

Mozaffari, S., Abdollahi, M.(2021). Mitochondrial contribution to cell death . Mitochondrial Metabolism: An Approach to Disease Management. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 49-60.